Dr. Maimuna Ahmed is the CTM/scientific officer at a phase 2 trial, based in Canada and a medical doctor from India. Dr. Ahmed's research is focused on anti-inflammatory approaches to target osteoarthritis using mesenchymal autologous cell therapy for osteoarthritis of all grades. Dr. Ahmed’s publication has attained Laureate status in Cureus and was cited in various journals. Dr. Ahmed is also researching the role of allogenic cells in osteoarthritis treatments, with the intention of contributing towards innovative treatments. Dr. Ahmed's committee received the Society of Clinical Research Associate Chapter Recognition Award (2022). Dr. Ahmed served on the Society of Clinical Research Associates (SOCRA) GTA chapter committee and sits on the CanReview tactical team. Dr. Ahmed is dedicated to delivering high-quality clinical trials and contributing to the development of safe and effective healthcare solutions. Her therapeutic experience spans psychiatry, musculoskeletal, immunology, oncology, and endocrinology.